中国临床保健杂志
中國臨床保健雜誌
중국림상보건잡지
CHINESE JOURNAL OF CLINICAL HEALTHCARE
2014年
5期
460-463
,共4页
汪鹏%兰雷%倪力军%任伟
汪鵬%蘭雷%倪力軍%任偉
왕붕%란뢰%예력군%임위
血液透析滤过%营养不良%酸中毒%碳酸氢钠
血液透析濾過%營養不良%痠中毒%碳痠氫鈉
혈액투석려과%영양불량%산중독%탄산경납
Hemodiafiltration%Malnutrition%Acidosis%Sodium bicarbonate
目的:探讨口服碳酸氢钠纠正酸中毒对维持血透患者营养状况的影响。方法入选30例透析前 HCO -3≤21 mmol/L 的维持血液透析患者,随机分为观察组和对照组,观察组给予碳酸氢钠口服。3个月后比较两组间以及观察组干预前后营养指标。结果①组间比较:观察组实际碳酸氢根(AB)、血尿素氮(BUN)、血磷较对照组升高(P <0.05);②观察组自身前后比较:干预后 AB(P <0.05)、肱三头肌皮褶厚度、网织红细胞比例、总胆固醇较干预前升高,高密度脂蛋白(HDL-C)较干预前降低(P <0.05)。结论口服碳酸氢钠治疗可以有效纠正维持性血液透析患者酸中毒并部分改善营养状况及贫血,但同时可能导致这部分人群血脂异常、血磷升高。
目的:探討口服碳痠氫鈉糾正痠中毒對維持血透患者營養狀況的影響。方法入選30例透析前 HCO -3≤21 mmol/L 的維持血液透析患者,隨機分為觀察組和對照組,觀察組給予碳痠氫鈉口服。3箇月後比較兩組間以及觀察組榦預前後營養指標。結果①組間比較:觀察組實際碳痠氫根(AB)、血尿素氮(BUN)、血燐較對照組升高(P <0.05);②觀察組自身前後比較:榦預後 AB(P <0.05)、肱三頭肌皮褶厚度、網織紅細胞比例、總膽固醇較榦預前升高,高密度脂蛋白(HDL-C)較榦預前降低(P <0.05)。結論口服碳痠氫鈉治療可以有效糾正維持性血液透析患者痠中毒併部分改善營養狀況及貧血,但同時可能導緻這部分人群血脂異常、血燐升高。
목적:탐토구복탄산경납규정산중독대유지혈투환자영양상황적영향。방법입선30례투석전 HCO -3≤21 mmol/L 적유지혈액투석환자,수궤분위관찰조화대조조,관찰조급여탄산경납구복。3개월후비교량조간이급관찰조간예전후영양지표。결과①조간비교:관찰조실제탄산경근(AB)、혈뇨소담(BUN)、혈린교대조조승고(P <0.05);②관찰조자신전후비교:간예후 AB(P <0.05)、굉삼두기피습후도、망직홍세포비례、총담고순교간예전승고,고밀도지단백(HDL-C)교간예전강저(P <0.05)。결론구복탄산경납치료가이유효규정유지성혈액투석환자산중독병부분개선영양상황급빈혈,단동시가능도치저부분인군혈지이상、혈린승고。
Objective To explore the effect of oral sodium bicarbonate to correct acidosis for nutrional status in maintenance hemodialysis(MHD)patients.Methods Thrity maintenance hemodialysis patients with MA(predial-ysis HCO -3 <21 mmol/L)were enrolled.They were randomly divided into experimental group and control group.Pa-tients in experimental group were administred oral sodium bicarbonate.The nutritional parameters were assessed 3 months later.Results ① Comparison between two groups after intervention:The HCO -3 (P <0.05),serum BUN and phosphorus level were significantly higher in experimental group than those in group;②Comparison between be-fore and after intervention within the experimental group:Compared with baseline, the HCO-3, TSF, total serum cho-lesterol, percent of reticulocyte were increased significantly, while HDL decreased significantly after intervention(all P<0.05). Conclusion Oral sodium bicarbonate supplementation can effectively correct acidosis in MHD pa-tients, and the therapy may led to the improvement of nutritional status and anemia. Meanwhile, oral sodium bicar-bonate supplementation maybe lead to elevation of serum phosphorus and dyslipidemia.